DGS Diagnostics

What DGS Diagnostics does

DGS Diagnostics Sp. z o.o. is a Polish-headquartered medical device manufacturer (Kołbaskowo / Rosówek) that designs, produces, and services the full spectrum of clinical instruments used in hearing and balance diagnostics. Its portfolio covers five core product categories: audiometry, tympanometry, auditory brainstem response (ABR) systems, otoacoustic emission (OAE) testers, and vestibular balance assessment and treatment chairs. End customers are audiologists, hearing specialists, ENT clinics, hospitals, and newborn screening programs; the chairs extend the clinical surface from diagnosis alone into balance-disorder treatment. The company was founded on March 6, 2009 as Diagnostics Polska Production (later LEDISO, then DGS Diagnostics from 2013) and operates as the diagnostics manufacturing arm of Danish holding Demant, supplying diagnostic instruments to seven brands within the parent group and distributing through a network that reaches 146 countries. Business model revenue comes from (i) hardware sales of diagnostic instruments and balance chairs, and (ii) recurring after-sales service and maintenance contracts over the equipment lifecycle, sold through a direct enterprise field-sales motion to healthcare providers globally. Pricing is quote-based with no public list pricing, consistent with B2B regulated medical device sales.

Operationally, DGS has scaled from a few operational areas at founding to more than 20 operational areas and approximately 500 employees by 2024, anchored since 2023 by a purpose-built production-warehouse-office complex in Rosówek featuring an Autostore automated warehouse and open-space offices. The company runs dedicated R&D (electronics, mechanical) and production teams, and absorbs adjacent capabilities such as the SMD team integrated in 2023. Management is led by Poland-based CEO Paweł Muklewicz (since 2016), with Demant group-level oversight from Diagnostics SVP Gitte Heede Hesel (since 2023) and President of Diagnostics Anne-Karen Hunt (since 2024). The company is private, does not disclose revenue, and operates as a non-listed subsidiary of Demant.

Name

DGS Diagnostics

Legal name

DGS Diagnostics

Website

https://dgs-diagnostics.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

101–250 employees

Short description

DGS Diagnostics is a Polish medical device manufacturer that designs, produces, and services audiometry, tympanometry, ABR, otoacoustic emission, and balance-disorder instruments for audiologists, ENT clinics, and hospitals worldwide.

Ownership category

akta.pro rank

Product category

Audiology and Balance Diagnostic Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Electronic and Precision Equipment Repair and Maintenance (81121)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Audiology & Hearing Diagnostic Centers (HLAFAKAH)

Keywords

• Hearing diagnostic devices
• Audiometry instruments
• Tympanometry equipment
• Balance disorder diagnostics
• Medical device manufacturing

Headquarters

HQ city

Kolbaskowo

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Medical Diagnostic Device Sales: Design, manufacture and sale of comprehensive hearing and balance diagnostic instruments including audiometry, tympanometry, ABR, and otoacoustic emission devices
2. After-Sales Service and Maintenance: Servicing of diagnostic equipment throughout product lifecycle
3. Balance Disorder Treatment Solutions: Specialized chairs for diagnosis and treatment of balance disorders

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

DGS Diagnostics designs, manufactures, and services a comprehensive spectrum of medical diagnostic instruments for hearing and balance assessment, including audiometry, tympanometry, ABR (Auditory Brainstem Response), otoacoustic emissions devices, and specialized balance disorder chairs. The company supplies these instruments globally to healthcare providers through its parent Demant group's distribution network, serving audiologists, ENT clinics, hospitals, and hearing specialists across 146 countries.

Product overview

DGS Diagnostics is a world leader in hearing and balance disorder diagnostics, manufacturing a comprehensive spectrum of diagnostic instruments. The product portfolio centers on five core instrument categories: audiometry, tympanometry, ABR (Auditory Brainstem Response), otoacoustic emissions, and balance disorder chairs. These devices enable hearing diagnosis and hearing aid fitting globally, while the specialized chairs allow for both diagnosis and treatment of balance disorders. The company supports 7 brands within the Demant group with these diagnostic solutions distributed to over 140 countries worldwide.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Products reach 146 countries worldwide
• +1 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• DemantflagshipOthersDGS Diagnostics belongs to Danish holding Demant, operating in hearing healthcare for over 120 years with branches in over 30 countries. Demant conducts four types of manufacturing: hearing aids, hearing implants, diagnostics, and communication. DGS supports 7 brands within the Demant group with diagnostic instruments.

Scale indicators5 records

Recent moves12 records

Expansion highlights5 records

Direct peers

• Inventis: Italian manufacturer of audiology and balance diagnostic equipment (audiometers, tympanometers, video head impulse test systems). Direct competitor in the European clinical audiology market.
• Otometrics: Demant-owned hearing and balance diagnostic instrument maker. Overlapping portfolio in audiometry and vestibular diagnostics; another internal Demant peer to DGS.
• Interacoustics: Also owned by Demant, Interacoustics manufactures audiometry, tympanometry, ABR, OAE, and balance assessment instruments — a near-mirror product line to DGS, making it the closest comparable peer (and internal sister division).
• MAICO Diagnostics: Manufactures screening and diagnostic devices for audiology (audiometry, tympanometry, OAE) with global distribution. Comparable product scope and customer base to DGS.
• Grason-Stadler (GSI): Specialist manufacturer of clinical audiometers, tympanometers, and OAE/ABR systems used in audiology and ENT practices. Directly competes with DGS in hearing diagnostics hardware.

Emerging players

• Starkey Hearing Technologies: US-based hearing aid manufacturer investing in diagnostics and fitting technology. Overlaps with DGS at the hearing aid fitting/diagnostics interface but primarily a hearing-aid brand rather than instrument maker.

Broad incumbents

• Natus Medical: Broader neurodiagnostic and hearing-screening device maker with overlap in ABR and OAE newborn screening products. Wider portfolio (EEG, sleep, NICU) but competes head-on in auditory diagnostics.
• Sonova: Swiss hearing healthcare giant (Phonak, Unitron) that also owns diagnostic instrument brands. Adjacent incumbent that competes for clinical audiology wallet share through integrated hearing-care solutions.
• GN Hearing: Hearing aids and audio solutions parent (ReSound, Jabra). Less direct overlap in diagnostic hardware, but a broad incumbent in the same end-customer category (audiology clinics and hearing care professionals).

Others

• Amplifon: Global hearing care retail and services operator. Not a diagnostic equipment maker, but an indirect customer/ecosystem participant — large-scale buyer of audiology diagnostic instruments and clinical services for its network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@dgs.diagnostics
• Facebookfacebook.com/dgs.diagnostics
• LinkedInlinkedin.com/company/dgs-diagnostics
• Instagraminstagram.com/dgs.diagnostics

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DGS Diagnostics